Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Azadeh Abravan"'
Autor:
Peter S. N. van Rossum, Celia Juan-Cruz, Barbara Stam, Maddalena M. G. Rossi, Steven H. Lin, Azadeh Abravan, José S. A. Belderbos, Jan-Jakob Sonke
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundSevere radiation-induced lymphopenia (RIL) in patients undergoing chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC) is associated with decreased immunotherapy efficacy and survival. At The Christie and MD Anderson Cancer Center
Externí odkaz:
https://doaj.org/article/2e6c1dc3c51e45f19a7dd9efbf06b813
Publikováno v:
Endocrine Connections, Vol 11, Iss 12, Pp 1-10 (2022)
Brain tumours make up nearly one-third of paediatric malignancies. Over time, advancements in oncological treatments like radiotherapy have helped reduce normal-tissue toxicity when treating cancers in the brain. However, clinicians are still facing
Externí odkaz:
https://doaj.org/article/1704c98a0d9046e08c5cb04b95fb7902
Autor:
Kathryn Banfill, Azadeh Abravan, Marcel van Herk, Fei Sun, Kevin Franks, Alan McWilliam, Corinne Faivre-Finn
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThere is increasing evidence of cardiac toxicity of thoracic radiotherapy however, it is difficult to draw conclusions on cardiac dose constraints due to the heterogeneity of published studies. Moreover, few studies record data on cause of
Externí odkaz:
https://doaj.org/article/203f3fe7b113404ebbec4564c0d6907b
Autor:
Azadeh Abravan, Gareth Price, Kathryn Banfill, Tom Marchant, Matthew Craddock, Joe Wood, Marianne C. Aznar, Alan McWilliam, Marcel van Herk, Corinne Faivre-Finn
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Radiation-induced heart disease (RIHD) is a recent concern in patients with lung cancer after being treated with radiotherapy. Most of information we have in the field of cardiac toxicity comes from studies utilizing real-world data (RWD) as randomiz
Externí odkaz:
https://doaj.org/article/4d1aaa2047aa40889b2d9a45e05c7ca0
Autor:
Alan McWilliam, Chloe Dootson, Lewis Graham, Kathryn Banfill, Azadeh Abravan, Marcel van Herk
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 15, Iss , Pp 46-51 (2020)
Background and purpose: For lung cancer patients treated with radiotherapy, radiation dose to the heart has been associated with overall survival, with volumetric dose statistics widely presented. However, critical cardiac structures are present on t
Externí odkaz:
https://doaj.org/article/45df172b6bfe4853b84a68029f8b5ca0
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 15-21 (2020)
Background: Lymphopenia during radiotherapy (RT) may have an adverse effect on treatment outcome. The aim of this study is to investigate associations between lymphopenia and RT parameters in patients with advanced lung cancer. Moreover, to investiga
Externí odkaz:
https://doaj.org/article/0f57ef78bc6e4ffc909a7cced857f0b1
Publikováno v:
Journal of Thoracic Oncology. 18:599-607
Autor:
Hanne A. Eide, MD, Ingerid Skjei Knudtsen, MSc, Vandana Sandhu, PhD, Ayca M. Løndalen, MD, Ann Rita Halvorsen, MSc, Azadeh Abravan, MSc, Elin H. Kure, PhD, Trond V. Bogsrud, MD, PhD, Odd Terje Brustugun, MD, PhD, Jon Amund Kyte, MD, PhD, Eirik Malinen, PhD, Åslaug Helland, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 2, Pp 130-138 (2018)
Purpose: Radiation therapy effectively kills cancer cells and elicits local effects in the irradiated tissue. The aim of this study was to investigate the kinetics of cytokines in the serum of patients with lung cancer undergoing radiation therapy an
Externí odkaz:
https://doaj.org/article/2d9cf0ea7ca544a9a5e11ec83551453d
Autor:
Azadeh Abravan, Hanne Astrid Eide, Ingerid Skjei Knudtsen, Ayca Muftuler Løndalen, Åslaug Helland, Eirik Malinen
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 4, Iss C, Pp 57-63 (2017)
Purpose: To investigate effects of radiotherapy (RT) and erlotinib on pulmonary glucose uptake using 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography (PET) during and after treatment of non-small cell lung cancer (NSCLC) and to
Externí odkaz:
https://doaj.org/article/d9fba4383eb842a6beeb1137af3382be
Publikováno v:
Lung Cancer. 178:S59-S60